Loading data
AWRENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 1.32 m USD | 835 k USD | 1.27 m USD | 1.26 m USD | 1.21 m USD |
| Research and development expense | 8.3 m USD | 7.76 m USD | 9.12 m USD | 9.23 m USD | 9.26 m USD |
| Operating profit | -6.56 m USD | -5.55 m USD | -8.54 m USD | -2.22 m USD | -6.1 m USD |
| Profit before tax | -5.62 m USD | -4.38 m USD | -7.26 m USD | -1.68 m USD | -6.09 m USD |
| Income tax expense | 300 k USD | 53 k USD | 59 k USD | 49 k USD | -269 k USD |
| Net income (reported basis) | 5.87 m USD | 4.43 m USD | 7.31 m USD | -1.73 m USD | -5.82 m USD |
| Basic earnings per share | -0.28 USD/share | -0.21 USD/share | -0.35 USD/share | -0.08 USD/share | -0.27 USD/share |
| Diluted earnings per share | -0.28 USD/share | -0.21 USD/share | -0.35 USD/share | -0.08 USD/share | -0.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.